Additionally, positive plasma GPC3 levels (≥ 132 ng/mL) were not associated with gender, maximum tumor size, ALT, hepatic virus infection, hepatic fibrosis, pre-AFP, pre-PIVKA-II, or GPC3 expression by immunohistochemistry (Supplementary Table 3). This evidence concerns the gene GPT and neoplasm.